Document Classification

Section Type: RESULTS

Text: At 6 months, 148 (10. 8 %) GIK infusion patients and 143 (10. 4 %) control patients died in the OASIS-6 trial (hazard ratio [HR], 1. 04 ; 95 % CI, 0. 83-1. 31 ; P =. 72) ; 153 (11. 1 %) GIK patients and 185 (13. 5 %) control patients had heart failure (HR, 0. 83 ; 95 % CI, 0. 67-1. 02 ; P =. 08) ; and 240 (17. 5 %) GIK patients and 264 (19. 2 %) control patients had a composite of death or heart failure (HR, 0. 91 ; 95 % CI, 0. 76-1. 08 ; P =. 27).